This is the authors' abstract. We don't add key points for this paper.
Prediabetes is a growing global concern, often progressing to Type 2 Diabetes Mellitus if unmanaged. ADCPT (Anti-Diabetes Collagen Peptide) is a novel nutritional intervention aimed at improving glucose metabolism and delaying diabetes onset. This 90-day, open-label, single-arm pilot study assessed ADCPT’s efficacy and safety in individuals with elevated blood glucose near the prediabetic range. Fifteen adults were enrolled, with eight included in the postprandial glucose (PPG) cohort. Participants received 5 g of ADCPT daily. Efficacy assessments included fasting blood glucose (FBG), glycated hemoglobin (HbA1c), and PPG, while safety was monitored through adverse events and routine clinical tests. The intervention demonstrated significant improvements in FBG, indicating ADCPT’s potential to regulate blood glucose. Although HbA1c and PPG did not reach statistical significance, they exhibited positive clinical trends. No significant adverse events were reported, confirming ADCPT’s safety. Further studies are necessary to validate these results.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Devasia et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: